Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension

Completed · Phase 4

Conditions studied: Hypertension

In brief

Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure

Key facts

Study ID

NCT00060931

Run by

GlaxoSmithKline

People needed

501

Starts

2001-06-01

Expected to finish

2004-04-01

Last updated by the study team

2015-04-14

Who can join

Age: 30 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients at screening must be insulin producing Type II diabetics (C peptide positive).
• Patients must have a history of mild to moderate hypertension (140-179 systolic blood pressure; 90-1-9 diastolic blood pressure)
• Patients must be on a stable regimen of ACE (angiotensin converting enzyme) / ARB (angiotensin receptor blocker) treatment alone or in combination with other treatments.
• Patients must be on stable antidiabetic regimen (drug treated or diet alone).
• Patient''s laboratory result for HbA1c must be 6.5 - 8.5 (drug treated) or 6.5 - 7.5 (diet alone).

You may not qualify if…

• Patients using beta-blocker therapy.

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Columbia, Alabama, United States
• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Derby, Connecticut, United States
• GSK Investigational Site — Farmington, Connecticut, United States
• GSK Investigational Site — Hartford, Connecticut, United States
• GSK Investigational Site — New Britain, Connecticut, United States
• GSK Investigational Site — Newark, Delaware, United States
• GSK Investigational Site — Washington D.C., District of Columbia, United States
• GSK Investigational Site — Washington D.C., District of Columbia, United States
• GSK Investigational Site — Coral Gables, Florida, United States
• GSK Investigational Site — Fort Lauderdale, Florida, United States
• GSK Investigational Site — Fort Lauderdale, Florida, United States
• GSK Investigational Site — Fort Meyers, Florida, United States
• GSK Investigational Site — Gainesville, Florida, United States
• GSK Investigational Site — Hollywood, Florida, United States
• GSK Investigational Site — Hollywood, Florida, United States
• GSK Investigational Site — Inverness, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Melbourne, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.